B4GALT1 Gene Glycosylation disorder type 2D NGS Genetic Test
Short Name: B4GALT1 NGS Test
Also known as: B4GALT1-CDG Genetic Test, CDG IId NGS Test, Beta-1,4-galactosyltransferase 1 gene analysis, Congenital Disorder of Glycosylation Type IId genetic testing
B4GALT1 Gene Glycosylation disorder type 2D NGS Genetic Test test available at DNA Labs India for ₹20,000. Uses Next-Generation Sequencing (NGS) on Blood or Extracted DNA or One drop Blood on FTA Card samples. Results in Reports are delivered online within 3 to 4 weeks once the sample reaches the laboratory.. Free home collection in 300+ cities across India.
🩺 Medically Reviewed By
Dr SULOCHANA HEMCHANDRA HOLLA
Consultant Medical Geneticist · Reg: 8532
Last reviewed: September 3, 2026
Overview
The purpose of this NGS genetic test is to identify disease-causing variants in the B4GALT1 gene that may be responsible for glycosylation disorder type 2D. It can help confirm a clinical diagnosis, support genetic counselling, assess recurrence risk, and guide appropriate medical management.
- Test Code
- 4117
- Price
- ₹20,000
- Sample Type
- Blood or Extracted DNA or One drop Blood on FTA Card
- Result Time
- Reports are delivered online within 3 to 4 weeks once the sample reaches the laboratory.
- Fasting Required
- No
- Method
- Next-Generation Sequencing (NGS)
Sample Collection
No fasting is required. The patient should provide a valid referral if available, complete the genetic counselling session, and share a detailed clinical history with the family pedigree.
Method: Peripheral blood draw or FTA card blood spot collection
Laboratory Analysis
A small blood sample will be collected by venipuncture, or one drop of blood may be applied on an FTA card. The procedure is quick and minimally invasive.
Report Delivery
No special precautions are needed. The patient can resume normal activities immediately after sample collection.
Timeline: Reports are delivered online within 3 to 4 weeks once the sample reaches the laboratory.
Patient Instructions
About This Test
Who Should Get This Test
The purpose of this NGS genetic test is to identify disease-causing variants in the B4GALT1 gene that may be responsible for glycosylation disorder type 2D. It can help confirm a clinical diagnosis, support genetic counselling, assess recurrence risk, and guide appropriate medical management.
How to Prepare
- Carry a valid doctor's prescription or referral if available
- Complete the patient consent and clinical history form
- For FTA card samples, apply one drop of blood to the marked circle and allow it to air dry
- Do not expose the FTA card to direct sunlight, heat, or moisture
- For extracted DNA samples, label the vial clearly with the patient's name and unique identifier
Doctor's Notes
Reviewed by Dr SULOCHANA HEMCHANDRA HOLLA — MBBS, MD (Medical Genetics) · Reg. No. 8532
"This test should be ordered when a congenital disorder of glycosylation is suspected. Results should be interpreted with biochemical data and clinical findings, and genetic counselling is recommended before and after testing, especially for family planning and recurrence risk assessment."
Last medically reviewed: September 3, 2026
Test Parameters & Specifications
Sample Stability
- Clotted or haemolysed blood sample
- Insufficient sample quantity
- Leaking or unlabelled sample container
- Improper storage or transit conditions leading to DNA degradation
- Sample received without consent or clinical history
Understanding Your Results
Confirmed disease-causing variant; consistent with B4GALT1-CDG if clinical features match
Very likely disease-causing; family testing and clinical correlation may be helpful
Not enough evidence to classify as pathogenic or benign; additional family or functional studies may be recommended
Probably not disease-causing; clinical correlation is still required
No disease association
If a child or adult shows unexplained developmental delay, intellectual disability, seizures, abnormal muscle tone, abnormal eye movements, or multi-organ dysfunction, a clinical geneticist or neurologist should be consulted. Genetic counselling is recommended before and after testing.
Limitations
- ⚠This test may not detect large gene rearrangements, deep intronic variants, mitochondrial mutations, or trinucleotide repeat expansions
- ⚠A negative result does not exclude all forms of congenital disorders of glycosylation
- ⚠Variants of uncertain significance may require additional segregation or functional studies
- ⚠Molecular test results should be interpreted alongside biochemical testing such as transferrin isoform analysis
Risks & Considerations
- ●Minimal pain or bruising at the blood collection site
- ●Lightheadedness during or after blood draw
- ●Very low risk of infection at the puncture site
Interfering Factors
- ●Severe haemolysis or clotted blood samples may reduce DNA quality
- ●Inadequate DNA quantity or quality
- ●Bacterial contamination of extracted DNA
- ●Sample mix-up or incorrect labelling
- ●Incomplete clinical or family history may limit interpretation
Compare With Similar Tests
| Test | B4GALT1 Gene Glycosylation disorder type 2D NGS Genetic Test | ||
|---|---|---|---|
| Comparison | B4GALT1 Gene Glycosylation disorder type 2D NGS Genetic Test | NGS can analyse the entire B4GALT1 gene in a single high-throughput assay, reducing time and cost. Sanger sequencing is often used to confirm a specific family variant or small targeted region. | Targeted NGS focuses specifically on B4GALT1, giving a lower cost and easier interpretation. Whole exome sequencing evaluates many genes simultaneously and is useful when the clinical picture is broad or unsolved. |
Frequently Asked Questions
What is B4GALT1 gene glycosylation disorder type 2D?
What does this NGS genetic test detect?
Who should undergo this test?
What sample is required for the B4GALT1 NGS test?
Is fasting required before the test?
How long will the reports take?
What is the cost of the B4GALT1 gene glycosylation disorder type 2D NGS test?
Is genetic counselling required?
How accurate is the NGS method?
Can a normal result completely rule out the disorder?
What are the limitations of this test?
How can I book this test at DNA Labs India?
Related Tests
Angelman Syndrome Test
₹10,000Duchenne / Becker Muscular Dystrophy (DMD / BMD) Gene Mutation Test
₹14,000Episodic Ataxia Type 1 Hotspot Test
₹11,500Episodic Ataxia Comprehensive Profile Hotspot Test
₹16,000Megalencephalic Leukoencephalopathy with Subcortical Cysts Van Der Knaap and Nalband MLC Gene Hotspot Mutation Test
₹7,500Analyzer 18 SMA 18 Test Panel
₹1,755Reference Laboratory Services
We serve as a reference laboratory for hospitals and clinics across India. Send samples from your facility with same-day pickup, priority processing, and results delivered through our online portal. Competitive institutional pricing available.
Your Data Privacy
Your medical data is protected under Indian law.
✓ Stored in India: All patient records are stored on servers located in India. No data is transferred outside the country.
✓ DPDP Act Compliant: Under the Digital Personal Data Protection Act 2023, you can request deletion of your records at any time by contacting support.
Book Your Test
Enter your details and we'll connect you within 15 minutes.
